Thinking Systems highlights PACS nuclear medicine functionalities

Thinking Systems Corp. emphasized the unique nuclear medicine capabilities that are a part of its ThinkingPACS workstation and other products at the 52nd Society of Nuclear Medicine (SNM) annual meeting in Toronto, Canada, June 18-22.

"We are trying to differentiate ourselves from the other PACS vendors," said Xiaoyi Wang, president and co-chairman, Thinking Systems. The company's products can handle modalities from all sides, including image archiving and a number of processing abilities in nuclear medicine, nuclear cardiology, and PET/CT, which no other company can provide, Wang said.

To emphasize this, Thinking Systems showcased its ThinkingPACS workstation which includes a number of features for nuclear cardiology as well as general nuclear medicine such as special tools for processing and quantitative analysis, and PET-CT fusion.

"Philips is selling our system to go with their PET/CT" because is it so much easier to work with than other workstations due to its speed (it's able collapse a number of processing steps into one screen), is based on open architecture, and features an easy-to-use standard Windows-based viewer, said Wang. The system does not use proprietary hardware but rather uses existing hardware and simply adds software to it.

"We take the functionality from the scanner to the PACS" so that clinicians can view and process images on any part of the PACS network, Wang said.

Also on display at SNM was ThinkingWeb which allows remote access to all of the functions that are available on the workstation via the web with a simple login through a web browser. When accessing the system remotely, the data and all the processing that is done are stored on the server-side and are not downloadeded on the local PC. This means that the information loads very quickly.

Thinking Systems also highlighted its ThinkingRIS, ThinkingReporting a web-based reporting system, and ThinkingReg.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.